Robotic Surgery in Rectal Cancer: Potential, Challenges, and Opportunities

Curr Treat Options Oncol. 2022 Jul;23(7):961-979. doi: 10.1007/s11864-022-00984-y. Epub 2022 Apr 18.

Abstract

The current standard treatment for locally advanced rectal cancer is based on a multimodal comprehensive treatment combined with preoperative neoadjuvant chemoradiation and complete surgical resection of the entire mesorectal cancer. For ultra-low cases and cases with lateral lymph node metastasis, due to limitations in laparoscopic technology, the difficulties of operation and incidence of intraoperative complications are always difficult to overcome. Robotic surgery for the treatment of rectal cancer is an emerging technique that can overcome some of the technical drawbacks posed by conventional laparoscopic approaches, improving the scope and effect of radical operations. However, evidence from the literature regarding its oncological safety and clinical outcomes is still lacking. This brief review summarized the current status of robotic technology in rectal cancer therapy from the perspective of several mainstream surgical methods, including robotic total mesorectal excision (TME), robotic transanal TME, robotic lateral lymph node dissection, and artificial intelligence, focusing on the developmental direction of robotic approach in the field of minimally invasive surgery for rectal cancer in the future.

Keywords: Colorectal cancer; RLLND; RTME; RTaTME; Robotic surgery.

Publication types

  • Review

MeSH terms

  • Artificial Intelligence
  • Humans
  • Laparoscopy* / adverse effects
  • Laparoscopy* / methods
  • Rectal Neoplasms* / pathology
  • Rectal Neoplasms* / surgery
  • Rectum / pathology
  • Rectum / surgery
  • Robotic Surgical Procedures* / adverse effects
  • Treatment Outcome